- Home
- IMVT vs NMRK Comparison
IMVT vs NMRK Comparison
Compare IMVT & NMRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- NMRK
- Stock Information
- Founded
- IMVT 2018
- NMRK 1929
- Country
- IMVT United States
- NMRK United States
- Employees
- IMVT N/A
- NMRK N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- NMRK Real Estate
- Sector
- IMVT Health Care
- NMRK Finance
- Exchange
- IMVT Nasdaq
- NMRK Nasdaq
- Market Cap
- IMVT 2.7B
- NMRK 3.1B
- IPO Year
- IMVT N/A
- NMRK 2017
- Fundamental
- Price
- IMVT $24.26
- NMRK $17.23
- Analyst Decision
- IMVT Buy
- NMRK Strong Buy
- Analyst Count
- IMVT 9
- NMRK 5
- Target Price
- IMVT $27.71
- NMRK $19.00
- AVG Volume (30 Days)
- IMVT 1.5M
- NMRK 1.3M
- Earning Date
- IMVT 11-10-2025
- NMRK 10-30-2025
- Dividend Yield
- IMVT N/A
- NMRK 0.69%
- EPS Growth
- IMVT N/A
- NMRK 94.50
- EPS
- IMVT N/A
- NMRK 0.59
- Revenue
- IMVT N/A
- NMRK $3,160,782,000.00
- Revenue This Year
- IMVT N/A
- NMRK $19.70
- Revenue Next Year
- IMVT N/A
- NMRK $9.58
- P/E Ratio
- IMVT N/A
- NMRK $29.48
- Revenue Growth
- IMVT N/A
- NMRK 20.95
- 52 Week Low
- IMVT $12.72
- NMRK $9.65
- 52 Week High
- IMVT $29.49
- NMRK $19.84
- Technical
- Relative Strength Index (RSI)
- IMVT 63.13
- NMRK 51.18
- Support Level
- IMVT $21.86
- NMRK $15.29
- Resistance Level
- IMVT $24.07
- NMRK $17.56
- Average True Range (ATR)
- IMVT 1.25
- NMRK 0.63
- MACD
- IMVT -0.18
- NMRK 0.14
- Stochastic Oscillator
- IMVT 83.68
- NMRK 83.23
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About NMRK Newmark Group Inc.
Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.